HomeSMNR • OTCMKTS
add
Semnur Pharmaceuticals Inc
Previous close
$21.00
Day range
$22.00 - $22.00
Year range
$9.00 - $22.00
Market cap
4.82B USD
Avg Volume
45.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 152.59M | 11,656.09% |
Net income | -152.59M | -11,656.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 85.00K | 494.95% |
Total assets | 774.00K | -91.33% |
Total liabilities | 15.37M | -16.35% |
Total equity | -14.59M | — |
Shares outstanding | 229.74M | — |
Price to book | -350.00 | — |
Return on assets | -7,743.53% | — |
Return on capital | -25,916.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -152.59M | -11,656.09% |
Cash from operations | -2.13M | -402.59% |
Cash from investing | — | — |
Cash from financing | 2.16M | 412.09% |
Net change in cash | 30.00K | 1,600.00% |
Free cash flow | 57.35M | 73,715.73% |
About
Founded
2013
Website
Employees
3
